Ignite Creation Date:
2024-05-06 @ 2:15 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04252768
Status:
WITHDRAWN
Last Update Posted:
2023-03-22
First Post:
2020-01-29
Brief Title:
A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti IMP321 Eftilagimod Alpha as Adjunctive to a Weekly Treatment Regimen of Paclitaxel
Sponsor:
Immutep SAS
Organization:
Immutep SAS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Breast Cancer |
Keywords: